![]() |
市场调查报告书
商品编码
1787924
多剂量包装系统市场预测至 2032 年:按产品、材料、药品类型、分销管道、技术、最终用户和地区进行的全球分析Multi-Dose Packaging System Market Forecasts to 2032 - Global Analysis By Product (Blister Packs, Pouches, Bottles, Sachets, Vials, Jars, Tubes and Other Products), Material, Drug Type, Distribution Channel, Technology, End User and By Geography |
根据 Stratistics MRC 的数据,全球多剂量包装系统市场预计在 2025 年将达到 37 亿美元,到 2032 年将达到 65 亿美元,预测期内的复合年增长率为 8.1%。
多剂量包装系统是一种药品包装技术,旨在将多剂量药物装入单一容器中。此系统常用于提高服药依从性,尤其是在慢性病患者以及医院和养老院等场所。这些方法通常按日期和时间安排剂量,从而减少漏服或错误用药的可能性。多剂量包装有瓶装、泡壳包装、袋装和其他多种包装形式,简化了监测和配药流程。此外,多剂量包装还能减少药物管理的浪费和错误,同时提高安全性、便利性和效率。
服药依从性和便利性的需求不断增加
有序且标籤清晰的包装对患者,尤其是老年人和长期患病患者,大有裨益。这些方法能够确保准确及时地用药,从而减少用药错误。为了提高病患的依从性,看护者和医护人员更倾向于使用多剂量包装。随着药房服务品质和安全性的提高,这些解决方案正被越来越多地采用。整体而言,市场扩张的驱动力是对药物管理准确性和效率的需求。
初期投资和营运成本高
中小型药局难以承担安装自动化包装设备所需的庞大成本。维护和员工培训进一步增加了营运成本。许多医护人员由于成本高而不愿放弃传统的包装方法。因此,市场渗透率仍然很低,尤其是在低度开发国家。总体而言,经济障碍阻碍了这些尖端解决方案的广泛应用。
与智慧技术和数位健康平台的集成
这些技术能够实现自动提醒和即时追踪,从而减少漏服或误服的几率。负责人可以透过智慧包装解决方案取得用药数据,从而实现更有效的监测和个人化治疗方案的调整。数位化连接进一步提升了供应链效率和库存管理。远端医疗的日益普及进一步增加了远端医疗的需求。这些发展改善了患者的治疗效果,并实现了药品配送方式的现代化。
严格的监管标准和包装废弃物问题
由于公司需要遵守严格的标籤、材料安全和剂量准确性规定,产品开发可能会被推迟。监管延迟也可能影响创新包装形式的及时推出。此外,对包装废弃物的日益担忧迫使公司投资永续材料,从而提高了製造成本。现有的多剂量包装设计在许多地方对回收和处置法规构成挑战。所有这些因素共同降低了盈利,并阻碍了新的竞争。
COVID-19的影响
新冠疫情 (COVID-19) 大流行显着影响了多剂量包装系统市场,增加了对安全高效药物分配的需求。医疗保健提供者寻求能够最大程度减少人际接触并降低污染风险的包装解决方案,从而推动了医院和药房对多剂量系统的采用。供应链中断和原材料短缺最初导致生产延迟,但对安全有序的药物管理的迫切需求刺激了对技术创新和自动化的投资。疫情也凸显了病患服药顺从性和安全性的重要性,进一步增强了该市场在全球医疗保健体系中的重要性。
预计预测期内瓶装饮料市场规模最大
由于瓶装产品在医药和医疗保健领域的广泛应用,预计在预测期内将占据最大的市场占有率。瓶装产品具有精准计量、可重复密封和防污染等特点,是多种用途的理想选择。其与各种液体和固体製剂的兼容性正推动市场采用。对易于使用且经济高效的包装解决方案的需求日益增长,推动了瓶装产品的偏好。此外,瓶装设计和永续材料的进步也支持了市场占有率的扩大。
预计在预测期内,养老院部门的复合年增长率最高。
由于老年人口不断增长,需要持续的药物管理,预计养老院市场将在预测期内呈现最高增长率。在这些机构中,药物管理的安全性和准确性至关重要,而多剂量包装可以减少用药错误,从而实现这一点。预包装剂量可以节省时间并简化配药流程,从而提高员工效率。随着监管机构越来越重视护理机构的用药依从性,对合规包装的需求也不断增长。因此,长期照护机构正在推动多剂量包装系统应用的持续成长。
在预测期内,由于老龄人口成长、慢性病盛行率上升以及医疗基础设施不断扩张,亚太地区预计将占据最大的市场占有率。中国、日本和印度等国家正在投资先进的医药包装技术,以提高病患依从性并减少用药错误。随着智慧药物管理意识的不断增强,以及快速的都市化和数位化医疗的普及,进一步推动了需求成长。本地企业正在积极创新,推出经济高效且永续的包装解决方案,以满足医院和居家照护环境日益增长的需求。
预计北美在预测期内的复合年增长率最高,这得益于严格的监管标准、先进的製药实践以及配药自动化的大力推广。美国和加拿大正致力于透过创新的泡壳包装和支援RFID技术的包装来最大限度地减少服药不遵从的情况。主要市场参与者的加入以及长期照护机构、疗养院和门诊病人服务日益增长的需求正在推动市场扩张。与电子健康记录(EHR) 和数位处方平台的整合正变得越来越普遍,这使得多剂量包装对于提高业务效率和患者预后至关重要。
According to Stratistics MRC, the Global Multi-Dose Packaging System Market is accounted for $3.7 billion in 2025 and is expected to reach $6.5 billion by 2032 growing at a CAGR of 8.1% during the forecast period. A pharmaceutical packaging technique called a multi-dose packaging system is made to include several doses of medication in one container. It is frequently used to increase drug adherence, especially for patients with chronic diseases and in environments like hospitals and assisted living facilities. These methods frequently arrange dosages according to date and time, which lowers the possibility of missing or giving the wrong dosage. Available in bottles, blister packs, or pouches, they simplify monitoring and dispensing. Additionally, multi-dose packaging reduces waste and mistakes in the administration and management of medications while improving safety, convenience, and efficiency.
Rising demand for medication adherence and convenience
Well-organised and labelled packaging is beneficial to patients, particularly the elderly and those with long-term illnesses. By guaranteeing precise and timely dosage, these methods lower pharmaceutical mistakes. For better patient compliance, carers and medical professionals favour multi-dose packs. These solutions are being adopted by pharmacies more frequently in an effort to improve service quality and safety. In general, market expansion is driven by the requirement for accuracy and efficiency in drug administration.
High initial investment and operational costs
Small and mid-sized pharmacies may find it difficult to afford the significant expenditure needed to set up automated packaging equipment. Operational costs are further increased by maintenance and employee training. Many healthcare practitioners are discouraged from abandoning traditional packing methods because to the hefty expenses. Consequently, there is still little market penetration, particularly in underdeveloped nations. Overall, financial obstacles prevent these cutting-edge solutions from being widely adopted.
Integration with smart technologies and digital health platforms
The chance of missing or giving the wrong dose is decreased by these technologies, which allow for automated reminders and real-time tracking. Healthcare practitioners can receive usage data via smart packaging solutions, enabling more effective monitoring and individualised treatment modifications. The efficiency of the supply chain and inventory management are further enhanced by digital connectivity. The need for intelligent packaging that supports remote care is further increased by the expanding use of telemedicine. All things considered, these developments enhance patient outcomes and modernise medication distribution methods.
Strict regulatory standards and packaging waste concerns
Product development may be slowed down by the need for businesses to adhere to strict labelling, material safety, and dosage precision regulations. The timely introduction of innovative packaging formats may also be impacted by regulatory delays. Furthermore, companies are being forced to invest in sustainable materials due to increased worries about packaging waste, which raises production costs. Existing multi-dose packaging designs are challenged by recycling and disposal regulations in many places. All of these elements work together to lower profitability and deter new competitors.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the Multi-Dose Packaging System Market by increasing demand for secure and efficient medication dispensing. Healthcare providers sought packaging solutions that minimized human contact and reduced the risk of contamination, driving the adoption of multi-dose systems in hospitals and pharmacies. Supply chain disruptions and raw material shortages initially slowed production, but the urgent need for safe, organized medication delivery fuelled innovation and investments in automation. The pandemic also emphasized the importance of patient adherence and safety, further strengthening the market's relevance in global healthcare systems.
The bottles segment is expected to be the largest during the forecast period
The bottles segment is expected to account for the largest market share during the forecast period, due to its widespread use in pharmaceuticals and healthcare. Bottles offer precise dosing, resealability, and protection from contamination, making them ideal for multi-use applications. Their compatibility with various liquid and solid formulations enhances market adoption. Growing demand for user-friendly and cost-effective packaging solutions boosts their preference. Additionally, advancements in bottle design and sustainable materials support their increasing market share.
The long-term care facilities segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the long-term care facilities segment is predicted to witness the highest growth rate, due to the rising elderly population requiring consistent medication management. These facilities prioritize safety and accuracy in drug administration, which multi-dose packaging supports by reducing medication errors. Staff efficiency improves as pre-packaged doses save time and streamlines dispensing processes. The demand for compliance packaging grows as regulatory bodies emphasize adherence in care settings. Consequently, long-term care facilities drive sustained growth in the adoption of multi-dose packaging systems.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising geriatric population, increasing prevalence of chronic diseases, and expanding healthcare infrastructure. Countries like China, Japan, and India are investing in advanced pharmaceutical packaging technologies to enhance patient compliance and reduce medication errors. Growing awareness of smart medication management, along with rapid urbanization and digital health adoption, further fuels demand. Local players are actively innovating with cost-effective and sustainable packaging solutions to cater to the rising need in hospital and homecare settings.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by stringent regulatory standards, advanced pharmaceutical practices, and strong adoption of automation in drug dispensing. The U.S. and Canada are focusing on minimizing medication non-adherence through innovative blister packs and RFID-enabled packaging. The presence of key market players and growing demand from long-term care facilities, nursing homes, and outpatient services amplify market expansion. Integration with electronic health records (EHRs) and digital prescription platforms are gaining traction, making multi-dose packaging essential for operational efficiency and improved patient outcomes.
Key players in the market
Some of the key players profiled in the Multi-Dose Packaging System Market include Omnicell, Inc., Swisslog Healthcare, Tosho Co., Ltd., Manrex Limited, Becton, Dickinson and Company (BD), McKesson Corporation, Cardinal Health, Inc., Baxter International Inc., Parata Systems, LLC, ScriptPro LLC, Yuyama Co., Ltd., ARxIUM Inc., JVM Co., Ltd., Accu-Chart Plus Healthcare Systems, Inc. and Euclid Medical Products.
In May 2025, Tosho unveiled enhanced specifications for the Xana 4001U2 Advance, a high-capacity full-automatic tablet packing system. Updates included improved drug recognition accuracy, faster multi-dose dispensing, and streamlined user interface for hospital and pharmacy operations, boosting productivity while maintaining strict medication safety and traceability standards.
In May 2025, Omnicell launched a new line of RFID-enabled products called MedTrack. These are designed for perioperative and clinic settings, offering advanced automation, intelligent software workflows, and enhanced medication inventory management. The platform aims to reduce medication errors and streamline multi-dose packaging processes through automated tracking and inventory control.
In April 2025, Swisslog Healthcare's AutoPack(TM) upgrades with the U Canister and Variable Heater enhance packaging flexibility and efficiency. The U Canister holds up to 280 tablets, including irregular sizes, while the Variable Heater supports customizable package lengths (50-95 mm), streamlining cartfill and ADU workflows-crucial for addressing staff shortages and optimizing multi-dose medication delivery.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.